Advisor Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $768K | Buy |
12,608
+8,780
| +229% | +$535K | 0.01% | 1372 |
|
|
2019
Q3 | $157K | Buy |
3,828
+973
| +34% | +$39.9K | ﹤0.01% | 2514 |
|
|
2019
Q2 | $134K | Sell |
2,855
-2,671
| -48% | -$125K | ﹤0.01% | 2632 |
|
|
2019
Q1 | $197K | Buy |
5,526
+950
| +21% | +$33.9K | ﹤0.01% | 2296 |
|
|
2018
Q4 | $131K | Sell |
4,576
-5,054
| -52% | -$145K | ﹤0.01% | 2412 |
|
|
2018
Q3 | $427K | Buy |
9,630
+1,609
| +20% | +$71.3K | ﹤0.01% | 1576 |
|
|
2018
Q2 | $471K | Buy |
8,021
+6,827
| +572% | +$401K | 0.01% | 1348 |
|
|
2018
Q1 | $55K | Buy |
1,194
+94
| +9% | +$4.33K | ﹤0.01% | 2981 |
|
|
2017
Q4 | $26K | Buy |
1,100
+200
| +22% | +$4.73K | ﹤0.01% | 3532 |
|
|
2017
Q3 | $16K | Hold |
900
| – | – | ﹤0.01% | 3681 |
|
|
2017
Q2 | $14K | Buy |
900
+600
| +200% | +$9.33K | ﹤0.01% | 3721 |
|
|
2017
Q1 | $7K | Buy |
+300
| New | +$7K | ﹤0.01% | 3956 |
|